4//SEC Filing
Evoli Lisa 4
Accession 0001209191-23-009704
CIK 0000917520other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:07 PM ET
Size
10.5 KB
Accession
0001209191-23-009704
Insider Transaction Report
Form 4
Evoli Lisa
Chief Human Resources Officer
Transactions
- Award
Common Stock
2023-02-13+1,552→ 19,549 total - Award
Common Stock
2023-02-13+632→ 20,181 total - Award
Common Stock
2023-02-13+1,054→ 21,235 total - Award
Common Stock
2023-02-13+1,137→ 22,372 total
Footnotes (3)
- [F1]On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.
- [F2]On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.
- [F3]On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.
Documents
Issuer
INTEGRA LIFESCIENCES HOLDINGS CORP
CIK 0000917520
Entity typeother
Related Parties
1- filerCIK 0001661715
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:07 PM ET
- Size
- 10.5 KB